Skip to content

Effectiveness of MOVI Interventions on Adiposity, Cognition and Subclinical Atherosclerosis: MOVI-daFit!

Effectiveness of MOVI Interventions on Improving Adiposity, Cognition and Subclinical Atherosclerosis by Increasing Aerobic Cardiorespiratory Fitness: MOVI-daFit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03236337
Enrollment
570
Registered
2017-08-01
Start date
2017-09-19
Completion date
2018-06-30
Last updated
2018-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiorespiratory Fitness, Cardiovascular, Children, Obesity, Physical Activity

Keywords

Physical activity, Obesity, Children, Cognitive function, Academic achievement, Cardiorespiratory fitness, Adiposity, Cardiovascular fitness, Atherosclerosis, Aerobic capacity

Brief summary

Project which objective is to test the effectiveness of an extracurricular physical activity intervention based on high intensity interval training (MOVI-daFit!) on improving cardiorespiratory fitness (CRF), cardiometabolic risk, executive function, and academic performance.

Detailed description

In the last decade, this research group has tested the effectiveness of three interventions following this model. The first one (MOVI) was carried out in peripuberal age children (4th and 5th year of primary education, 8-11 years) and showed a moderate effect in reducing the adiposity of schoolchildren with higher BMI, an improvement of the lipid profile, without significantly improving the global cardiometabolic risk because it did not produce a reduction in insulinemia. The second edition (MOVI-2), carried out at schoolchildren of the same age range, increased the duration and intensity of the sessions, and was focused on the development of muscular strength in order to improve insulinemia levels. The intervention showed proved effectiveness; in addition, the data from this intervention showed a modest improvement in girls' aerobic capacity, but not in boys. The last edition (MOVI-KIDS) was aimed at children aged 4 to 7 years to test the hypotheses that vigorous physical activity at early ages could produce lifelong cardio-metabolic benefits. Data submitted for publication in this study show that, as in the case of the IDEFICS study in children of similar age, the intervention was not effective in improving fitness. This new edition (MOVI-daFit!) has been designed as controlled cluster-randomized trial including 10 schools from Cuenca province, Spain. Five schools will be randomized to intervention group (IG), in which the intervention MOVI-daFit! will be conducted for children in fourth and fifth school grades (9-11 years old). The other five schools will be allocated to the control group (CG). During an academic year the 4th and 5th schoolchildren allocated to IG will be carry out, in out of school hours, four times by week, one hour sessions of a standardized recreative, non competitive, physical activity intervention based on games adapted to high intensity interval training methodology (MOVI-daFit!). In the CG regular physical activity will continue. At the end of the school year the researchers will determine main outcome variables: changes in VO2max, body fat by bioimpedance, reactive hyperemia index, academic achievement, executive function, and biochemical analytic procedures including lipid profile, insulin, HbA1, C ultrasensitive reactive protein and BDNF. The hypotheses of this new edition will be that the MOVI-daFit! based on high intensity interval training (HITT) adapted for the 4th and 5th schoolchildren, will: 1. Increase the aerobic capacity (VO2max). 2. Reduce the percentage of body fat in the GI versus the GC by 6%. 3. Improve executive function and academic performance. 4. Improve subclinical markers of atherosclerosis (endothelial function and carotid intima-media thickness).

Interventions

MOVI-da Fit! is a multidimensional intervention that consists on: a) 4h/week of a standardized recreative, non-competitive physical activity extracurricular program; and b) informative sessions to parents and teachers about how schoolchildren can became more active. It is aimed to enhance physical fitness, motor skills, physical activity time and active behaviours among 9-to-11 years old children.

Sponsors

Carlos III Health Institute
CollaboratorOTHER_GOV
University of Castilla-La Mancha
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* Schools must have at least one full classrooms for both the 4th and 5th grade of primary school. * The approval of boards of governors will be necessary. * Children's parents or legal representatives will sign an informed consent to participate. * Parents will be invited to collaborate by filling in questionnaires with regard to family leisure habits, sleeping, eating and getting around town.

Exclusion criteria

* Severe Spanish language learning difficulties. * Serious physical or mental disorders identified by parents or teachers that would impede participation in the programme's activities. * Children diagnoses of chronic disorders, such as heart disease, diabetes or asthma, which in the opinion of their paediatricians would prevent their participation in the programme's activities (MOVI-daFit!).

Design outcomes

Primary

MeasureTime frameDescription
VO2 maxOne yearIt will be assessed by using 20-m shuttle run test, which is validated to measure maximal aerobic capacity in children from 5 years.

Secondary

MeasureTime frameDescription
BDNF blood determinationOne yearBiochemical determinations will be performed in order to determine Brain-derived neurotrophic factor. It is a protein that, in humans, is encoded by the BDNF gene. BDNF acts on certain neurons of the central nervous system and the peripheral nervous system, helping to support the survival of existing neurons, and encourage the growth and differentiation of new neurons and synapses. In the brain, it is active in the hippocampus, cortex, and basal forebrain-areas vital to learning, memory, and higher thinking.
Health-related quality of lifeOne yearBy using the KIDSCREEN-27 for children from 8 years.
Sleep behaviors and sleep problems by questionnaireOne yearBy using the Spanish version of the Children's Sleep Habits Questionnaire (CSHQ) completed by parents. Four questions will be added in order to ask about bedtime, waking up, getting up, and total number of hours of sleep.
Sleep quality by accelerometryOne yearThe latency, quantity, duration of sleep and the number of awakenings will also be measured by accelerometry in a subsample of 242 school children. Actigraphy (ACT) is a non-invasive method used to study sleep-wake patterns and circadian rhythms by assessing movement. The GENEActive (ActivInsights) monitor will be used, a wristwatch device that monitors activity levels for extended continuous periods.
Motor skillsOne yearBy using the Movement Assessment Battery for Children 2 (M-ABC 2)
Physical activityOne yearIn a sub-sample of 242 randomly selected school children will be measured objectively by GENEActive (ActivInsights) accelerometers during seven consecutive days (including nights), with a fixed frequency of 85.7Hz to collect raw acceleration data measured in g for each axis of motion (x, y, z).
Body fat%One yearBody fat percentage measured by Bioimpedance analysis
Insulin profileOne yearInsulin (µU/L) level will be determined by using the Architect platform of Abbott ®
Arterial StiffnessOne yearCarotid intima-media thickness measurement through Sonosite Micromax ultrasound (Sonosite Inc., Bothell, Washington, USA).
Pulse wave velocityOne yearPulse wave velocity measurement through SphymgoCor System (AtCor Medical Pty Ltd Head Office, West Ryde, Australia)
Subclinical atherosclerosisOne yearReactive Hyperemia index measurement through ENDO- PAT (Moerland et al. Int J Vasc Med, 2012; 17; 682-86)
Executive functionOne yearExecutive function will be measured by standardized tests using the NIH toolbox
Glucose profileOne yearGlucose (mg/dl) level will be determined by using a system Cobas 8000 of Roche Diagnostics
Lipid profileOne yearApolipoproteins (mg/dl) level will be determined by using a system Cobas 8000 of Roche Diagnostics.
Ultrasensitive protein profileOne yearC-reactive protein ultrasensitive (mg/l) level will be determined by using a system Cobas 8000 of Roche Diagnostics
Academic achievementOne yearChildren´s mean scores on mathematics and language will be considered

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026